predicting time to death after withdrawal of life ... · tory death. methods: we systematically...
TRANSCRIPT
Laveena MunshiSonny DhananiSam D. ShemieLaura HornbyGenevieve GoreJason Shahin
Predicting time to death after withdrawalof life-sustaining therapy
Received: 6 January 2015Accepted: 17 March 2015Published online: 6 May 2015� Springer-Verlag Berlin Heidelberg andESICM 2015
Take-home message: There currentlyexists significant heterogeneity in studiesevaluating time to death after thewithdrawal of life-sustaining therapy.However, our evaluation of current datarevealed that controlled ventilation,oxygenation, vasopressor use, GlasgowComa Scale/Score and brain stem reflexeswere most consistently associated with ahastened time to death. More rigorousresearch evaluating these important riskfactors is needed in the general intensivecare unit population as well in patients inspecialized units and in donation aftercardiac death candidates.
Electronic supplementary materialThe online version of this article(doi:10.1007/s00134-015-3762-9) containssupplementary material, which is availableto authorized users.
L. MunshiInterdepartmental Division of Critical CareMedicine, and Department of Medicine,University of Toronto, University HealthNetwork and Mount Sinai Hospital,Toronto, Canada
S. DhananiDivision of Pediatric Critical Care, Facultyof Medicine, University of Ottawa, Ottawa,ON, Canada
S. Dhanani � L. HornbyChildren’s Hospital of Eastern OntarioResearch Institute, Ottawa, ON, Canada
S. D. ShemiePediatric Critical Care, Montreal Children’sHospital, McGill University Health Centre,McGill University, Montreal, QC, Canada
G. GoreSchulich Library of Science andEngineering, McGill University, 809Sherbrooke Street West, Montreal H3A0C1, Canada
J. Shahin ())Department of Critical Care, Department ofMedicine, Respiratory Division, RespiratoryEpidemiology Clinical Research Unit,McGill University Health Centre, 3650St-Urbain, Montreal, QC H2X 2P4, Canadae-mail: [email protected].: ?1-514-9341934
Abstract Purpose: Predictingtime to death following the with-drawal of life-sustaining therapy isdifficult. Accurate predictions maybetter prepare families and improvethe process of donation after circula-tory death. Methods: Wesystematically reviewed any predic-tive factors for time to death afterwithdrawal of life support therapy.Results: Fifteen observational stud-ies met our inclusion criteria. Theprimary outcome was time to death,which was evaluated to be within 60min in the majority of studies (13/15).Additional time endpoints evaluatedincluded time to death within 30,
120 min, and 10 h, respectively.While most studies evaluated riskfactors associated with time to death,a few derived or validated predictiontools. Consistent predictors of time todeath that were identified in five ormore studies included the followingrisk factors: controlled ventilation,oxygenation, vasopressor use, Glas-gow Coma Scale/Score, and brainstem reflexes. Seven unique predic-tion tools were derived, validated, orboth across some of the studies.These tools, at best, had only mod-erate sensitivity to predicting the timeto death. Simultaneous withdrawal ofall support and physician opinionwere only evaluated in more recentstudies and demonstrated promisingpredictor capabilities. Conclu-sions: While the risk factorscontrolled ventilation, oxygenation,vasopressors, level of consciousness,and brainstem reflexes have beenmost consistently found to be associ-ated with time to death, the additionof novel predictors, such as physicianopinion and simultaneous withdrawalof all support, warrant further inves-tigation. The currently existingprediction tools are not highly sensi-tive. A more accurate andgeneralizable tool is needed to informend-of-life care and enhance the pre-dictions of donation after circulatorydeath eligibility.
Intensive Care Med (2015) 41:1014–1028DOI 10.1007/s00134-015-3762-9 SYSTEMATIC REVIEW
Keywords Withholding treatment �Life support care � Death �
Time factors �Donation after cardiac death
Introduction
The decision to withdraw life-sustaining therapy (WLST)is the most common event prior to death in the intensivecare unit (ICU) [1]. A recent analysis of withdrawalpractices demonstrated that while the majority of patientsdie within 24 h, the ability to predict time to death may notbe accurate and occasionally is unexpectedly prolonged[2]. Accurate prediction of the time to death would allowfamilies to prepare for the loss of their loved one duringterminal care in the ICU and can help improve the processof donation after circulatory death (DCD). ControlledDCD is a method by which patients can become organdonors after WLST, with death determined on the basis ofcirculatory criteria. Approximately 20–30 % of consenteddonors do not die within the time limits required to permitDCD, resulting in false expectations for families andconsumption of hospital resources [3]. The ability to ac-curately predict time to death is crucial to identifyingsuitable donors, as a protracted time to death exposes theorgans to a prolonged warm ischemic time, rendering themless desirable for transplantation [4]. Having the ability toestimate warm ischemic time would assist healthcareproviders to determine donation potential, inform familyon the likelihood of successful donation, minimize emo-tional distress for families and for healthcare providersthemselves, and optimize hospital resource use.
A variety of prediction tools have attempted to predicttime to death following WLST. However, given con-flicting results and lack of external validity, these have notbeen widely adopted. The aim of this study was to per-form a systematic review to identify factors and riskprediction tools associated with time to death in thegeneral ICU population as well as in the setting of con-trolled DCD.
Methods
Search strategy
We searched MEDLINE via OVID (1946 up to present)and PubMed, EMBASE via OVID (1947 up to present),and CENTRAL (inception up to August 2014). We ex-amined reference lists of all included articles and relevantreview articles to identify any additional inclusions.Clinical experts, unpublished studies, and ongoing trialswere explored for inclusion; however, conference ab-stracts and gray literature were not reviewed. Our searchcombined Medical Subject Headings (MeSH; or appro-priate controlled vocabulary) and keywords for time,
death, and withdrawal [Electronic Supplementary Mate-rial (ESM) Appendix 1]. There were no languagerestrictions.
Study selection
Randomized controlled trials, observational cohort, andcase–control studies were included. The patient popula-tions included any patient beyond the neonatal periodwho underwent WLST in the ICU. The minimumdefinition of life-sustaining therapy included any invasiveor non-invasive mechanical ventilation or hemodynamicsupport. Studies examining any variables associated withtime to death were evaluated. Specifically, studies ex-amining risk factors, risk prediction models, clinicaldecision-making tools, or validation of any existing toolswere included. Given the large number of confoundersavailable, only studies that adjusted for confounding wereincluded.
Two reviewers (LM, JS) independently reviewed thetitles and abstracts identified in the literature searches.Full texts were retrieved and reviewed. Any disagree-ments were resolved by overall group consensus (LM,SD, JS). The final list of included studies was assessed forquality of methods.
Data extraction and quality assessment
The two reviewers (LM, JS) independently extractedrelevant data using a customized form developed by ourgroup. Study methodology and reporting were assessedindependently. Given that no gold standard exists for themethodological assessment of risk factor studies, thequestions were drawn from a previously published riskfactor/risk prediction tool systematic review [5]. Tenquestions assessed the methodology; study objectives,outcome description, patient characteristics, multicenterrecruitment, existence of an a priori analysis plan, ad-justment for known risk factors, rationale behind riskfactor inclusion and definition of risk factors, adequacy ofsample size, risk factor selection, and model strategychoice were all considered.
The primary outcome was time to death followingWLST in the ICU. Our aim was to explore factors foundto be statistically significant on multivariable analysis tobe associated with time to death. We also assessed thesuccessful prediction of time to death using a clinicaldecision support tool. Subgroup analysis was performedin studies focusing on DCD. A DCD-like study was
1015
defined as any study in which the patients were identifiedas either DCD candidates or as being similar to those whowould be DCD candidates according to the criteria oforgan procurement agencies.
Data analysis
Given that the data were derived exclusively from ob-servational studies with heterogeneous approaches toanalysis, we did not pool the data or subject it to meta-analysis. Rather, we summarized the literature, and dataanalysis consisted of a tabulation of study characteristics.
Results
The electronic search retrieved 1842 citations resulting in41 full-text articles for review (Fig. 1). Fifteen observa-tional studies fulfilled our inclusion criteria, 13 of whichevaluated an adult population and two a pediatric popula-tion [1, 6–19]. In all studies, with one exception [2], time todeath as an outcome was dichotomized. Time of death
within 60 min was the primary outcome in 13 of the 15included studies, with assessments of 5173 patients [6–18].Three studies additionally evaluated time to death within120 min [6, 12, 14]. Two studies evaluated factors associ-ated with time to death without specifying a time cutoff [2,19], one study included time to death within 30 min [13],and one study included time to death within 10 h [10].Baseline characteristics are summarized in Table 1. Twostudies were derived from one single cohort, with one ofthese studies reporting the results of the entire cohort andthe second study focusing on the potential DCD group [9,11]. Median age among the study population ranged be-tween 45 and 71 years in the adult studies and between 10and 24 months in the pediatric studies. The percentage ofadult patients who died within 60 and within 120 minranged between 44 and 71 % and between 54 and 83 %,respectively. Data for the other time-points were notavailable. One pediatric study reported on the percentage ofpatients who died within 30 and within 60 min, which wasfound to be 72 and 85 %, respectively [13]. The studieswere clinically heterogeneous with regard to patientpopulation and method of WLST. Methodologically, thestudies were also heterogeneous. Although most studiesperformed an exploratory analysis of risk factors of time todeath, only a few studies derived prediction tools of time todeath, and even a smaller subset validated previouslyderived prediction tools (Table 1). Seven studies evaluatedDCD-like patients [6–9, 13, 14, 16], and one studyevaluated identified actual DCD candidates [17]. Thedefinition for a DCD-like patient varied with each study(Table 1). Etiology of admission to ICU was pre-dominantly catastrophic neurologic disorders, followed bycirculatory and respiratory failure. Withdrawal of life-sustaining therapy consisted of withdrawal of ventilatorsupport in all studies (extubation or disconnection) andcessation of vasoactive medications in most studies. Adetailed overview of the specific components of the with-drawal process and whether it occurred simultaneously orin a staged fashion was not described in detail in moststudies (Table 1). Study quality across most of the studieswas noted to be generally moderate to high with respect toclearly identified objectives, multicenter nature, incorpo-ration of major known risk factors, and description of thestatistical model employed. The methodological assess-ment is summarized in Table 2.
Risk factors associated with time to death
Independent risk factors associated with time to deathusing multivariable logistic regression are summarized inTable 3. The majority of these studies focusedspecifically on time to death within 60 min [7, 8, 10–18].There was considerable variability between studies re-garding key predictor risk factors associated with time todeath. Risk factors that were persistently found to beFig. 1 Flow diagram of study selection. ICU Intensive care unit
1016
Tab
le1
Baselinestudycharacteristics
Studya
Studytype
Population
DCDbvs.
general
ICU
population
Age(SD
orIQ
R)
ICU
type
(npatients)
Componentsof
withdrawalc
Methodsof
withdrawald
(sim
ultaneous,
staged
ornot
specified)
Cause
for
withdrawal
Outcome
assessed
Percentage
death
within
60min
Adultpopulation
Brieva[9]
Australia
Predictiontool
derivation
DCDe
55(17)f,
54(22)
Mixed
ICU
(318)d
Mechanical
ventilator
Vasopressors/inotropes
Cardiacpacing
ECMO
IABP
RRT
Notspecified
NA
Death
within
60min
50%
Huynh[10]
USA
Riskfactoranalysis
General
62(16)
Mixed
(157)
Mechanical
ventilator
Notspecified
NA
Predictors
oftimeto
death
andtimeto
death
within
60min
and10h
Mediantimeto
death
(54min;IQ
R12–408)
NA
Brieva[11]
Australia
Riskfactoranalysis
andpredictiontool
derivation
General
66(20)
Mixed
ICU
(765)
Mechanical
ventilator
Vasopressors/inotropes
Cardiacpacing
ECMO
IABP
RRT
Notspecified
NA
Death
within
60min
49.3
%
DaV
ila[17]UK
Riskfactoranalysis
andpredictiontool
derivation
DCD
45(16)
NA
(420)
Mechanical
ventilator
Supportivedrugs
Sim
ultaneous
withdrawal
ofall
support
CNS(63%)
Hypoxia
(13%)
Cardiac(11%)
Death
within
60min
71%
deG
root[8]
Netherlands
ValidationofYee
etal.[15]prediction
tool
DCD
56(15–18)
Mixed
ICU(82)
Mechanical
ventilator
Antibiotics
Inotropic
agents
Notspecified
CNS
Death
within
60min
61%
Rabinstein[12]
USA/
Netherlands
Riskfactoranalysis
(evaluationof
predictors
identified
inYee
etal.tool[15]
ValidationofYee
etal.[15]prediction
tool
General
63(17)
NA
(178)
Mechanical
ventilator
Sedation
Opiate
analgesia
Notspecified
CNS
Death
within
60min
and120min
46%
(60min)
54%
(120min)
Wind[14]
Netherlands
Riskfactoranalysis
andpredictiontool
derivation
DCD
52(13)
Mixed
ICU
(211)
Mechanical
ventilator
Analgesia
andsedation
Inotropic
support
Mechanical
ventilatorand
inotropes
simultaneously
Analgesicsand
sedatives
not
specified
CNS
Death
within
60min
and120min
76%
(60min)
83%
(120min)
Yee
[15]USA
Riskfactoranalysis
General
NA
Neuro
ICU
(149)
Mechanical
ventilator
Notspecified
CNS
Death
within
60min
50%
1017
Table
1continued
Studya
Studytype
Population
DCDbvs.
general
ICU
population
Age(SD
orIQ
R)
ICU
type
(npatients)
Componentsof
withdrawalc
Methodsof
withdrawald
(sim
ultaneous,
staged
ornot
specified)
Cause
for
withdrawal
Outcome
assessed
Percentage
death
within
60min
Cooke[2]USA
Riskfactoranalysis
General
71
Mixed
ICU
(1505)
Mechanical
ventilator
Notspecified
Respiratory
Neurologic
Cardiac
Infectious
Trauma
Gastrointestinal
Malignancy
Predictors
oftimeto
death
Mediantimeto
death
(55.8
min;IQ
R15–330)
Suntharalingam
[16]UK
Riskfactoranalysis
DCD
44(16-65)
Renal
transplant
centers/
General
ICU
(191)
Mechanical
ventilator
Inotropes/vasopressors
Sim
ultaneous
withdrawal
CNS
Death
within
60min
56.5
%
Coleman
[18]
Australia
Evaluationof
previousprediction
tools(W
isconsin
Tool,UNOSTool,
HunterNew
EnglandArea
Score,ICU
staff
prediction)
General
66(15)
Mixed
ICU(81)
Mechanical
ventilator
Oxygen
supplementation
Vasopressors/inotropes
CardiacPacing
ECMO
IABP
RRT
Sedatives
andanalgesia
initiatedfollowing
withdrawal
Notspecified
Cardiac
Multiorgan
dysfunction
syndrome
CNS
Death
within
60min
44%
DeV
ita[7]USA
Riskfactoranalysis,
predictiontool
derivation,
validationof
UNOS
General
DCD
subgroup
57(54-77)
Mixed
ICU
(505)
Mechanical
ventilator
Vasopressors/inotropes
Analgesia
andsedation
ECMO
Ventricularassistdevice
IABP
Pacem
aker
Notspecified
Respiratory
failure
(96%)
CNSfailure
(55%)
Circulatory
failure
(49%)
Postcardiac
arrest
(23%)
Death
within
60min
45.0
%
Lew
is[6]
(Wisconsin
Tool)
USA
Predictiontool
derivation
DCD
NA
Mixed
ICU(43)
Mechanical
ventilator
Vasopressors/inotropes
ECMO
(veno-arterial)
Berlinheart
Notspecified
CNS
Death
within
60min
and120min
56%
(60min)
65%
(120min)
Pediatric
population
Shore
[13]USA
Riskfactoranalysis
andpredictiontool
derivation
DCD
10months
(1 month–
6years)
Mixed
(Pediatric)
ICU
(518)
Mechanical
ventilator
Vasopressors/Inotropes
Notspecified
CNS
Respiratory
failure
Congenital
cardiacdisease
Death
within
30min
and60min
72%
(30min)
87%
(60min)
1018
Table
1continued
Studya
Studytype
Population
DCDbvs.
general
ICU
population
Age(SD
orIQ
R)
ICU
type
(npatients)
Componentsof
withdrawalc
Methodsof
withdrawald
(sim
ultaneous,
staged
ornot
specified)
Cause
for
withdrawal
Outcome
assessed
Percentage
death
within
60min
Zaw
istowski
[19]
USA
Riskfactoranalysis
General
24months
Mixed
(Pediatric)
ICU
(50)
Mechanical
ventilator
Vasopressors/Inotropes
ECMO
Ventricularassistdevice
IABP
Pacem
aker
RRT
Horm
onetherapy
Antimicrobials
Analgesia
andsedation
80%
underwent
simultaneous
withdrawal
within
5min
Respiratory
Cardiac
Liver
disease
Predictors
oftimeto
death
Mediantimeto
death
[15min;IQ
R5,3)
NA
CNSCentral
nervoussystem
,DCDdonationaftercardiacdeath,ECMOextracorporealmem
braneoxygenation,IABPintraaorticballoonpump,ICUintensivecare
unit,IQ
Rinterquartilerange,NA
notavailable,NOSnototherwisespecified,RRTrenal
replacementtherapy,SD
standarddeviation,UNOSUnited
Network
forOrgan
Sharing
aInform
ationispresentedas
thefirstauthorofthestudy,reference
number
inreference
list,andcountryin
whichthestudywas
conducted
bDCDpotentialaccordingBrievaetal.[9]:agegroup(notspecified)andlack
ofmalignancy.DCDpotentialaccordingto
DeV
ilaetal.[11]:DCDacceptedliver
transplantofferspriorto
withdrawal
oflife-sustainingtherapy(LST),detailsnotprovided
onselectioncriteria.DCDpotentialaccordingto
DeG
rootetal.[8]:patientswhodiedas
aconsequence
ofsubarachnoid
hem
orrhage,traumatic
brain
injury,orintracerebralhem
orrhage;DCDpotentialaccordingto
Shore
etal.[13]:pediatricpatientsundergoingwithdrawalofLST.DCDpotentialaccordingto
Windetal.[14]:those
patients
whousually
suffer
from
irreversible
neurologic
injury.DCD
potential
accordingto
Suntharalingam
etal.[16]:aged
16–65years,history
ofhuman
immunodeficiency
virus,suspectednew
-variant
Creutzfeld-Jacobdisease,untreatedmajorsepsis.
DCD
potential
accordingto
DeV
itaet
al.[7]:
DCD
subgroup,age\60years,creatinine\2mg/dL,nooverwhelmingsepsis.
DCD
potential
accordingto
Lew
iset
al.[6]:severebrain
injury
receivingmechanical
ventilationforwhom
aphysician
isevaluatingforbrain
death
withaGlasgow
ComaScore
(GCS)of\5,planforLST
withdrawal
dTotalnumber
indevelopmentalsetandvalidationset
cNotallpapersincluded
adetailedoverview
ofthecomponentswithdrawnormethodsofwithdrawal;therefore
thecomponentsandmethodsofwithdrawal
may
notbelimited
tothelistsabove
eDCD
subgroupofcohortincluded
inthestudyofBrievaet
al.[11](2013)
fNote:foradultstudies,themedianagefordeath
ingiven
inyears;forpediatric
studies,medianagefordeath
isas
indicated.Dataarepresentedas
medianagefortimeto
death
within
60min,
followed
bymedianagefortimeto
death
of[60min
1019
Table
2Methodologyassessment
Studya
Objectives
clearly
described
Main
out-
come
mea-
sures
clearly
identified
Multicenter
nature
Analysis
defined
apriori
Did
the
analysis
accountforma-
jor
known
risk
factors
Rationale
behind
the
inclusion
of
the
risk
factors
included
Were
risk
factors
clearly
defined
Riskfactorselectionformodel
Statistical
model
Huynh[10]
USA
YY
NY
YY
YA
prioriselection,previous
literature,investigator
Allvariableskeptin
Cox
proportional
hazardsmodel
and
logisticregressionmodels
Brieva[9,11]
Australia
YY
YY
YY
YPreviousliterature,investigator,
univariable
analysis
Unclear
Davila[17]UK
YY
NY
YY
YPreviousliterature,investigator,
univariable
analysis
Forw
ardselection
deG
root[8]
Netherlands
YY
NY
YY
YPreviousliterature,investigator,
univariable
analysis
Allvariableskeptin
model
Rabinstein[12]
USA/
Netherlands
YY
YY
YY
YPreviousliterature,investigator,
univariable
analysis
Allvariableskeptin
model
Shore
[13]USA
YY
NY
YY
YUnivariable
analysis
Forw
ardselection
Wind[14]
Netherlands
YY
YY
YN
YUnivariable
analysis
Forw
ardselection
Yee
[15]USA
YY
NY
YY
YUnivariable
analysis
Unclear
Cooke[2]USA
YN
YY
YN
YA
prioriselection
Allvariableskeptin
model
Suntharalingam
[16]UK
YY
YY
YN
YA
prioriselection,previous
literature,investigator
Backwardandforw
ardselection
Coleman
[18]
Australia
YY
YY
YY
YNA
Unclear
Devita[7]USA
YY
YY
YY
YPreviousliterature,investigator,
univariable
analysis
Backwardandforw
ardseletion
Zaw
istowski
[19]
USA
YY
NN
YN
NNA
Unclear
Lew
is[6]USA
YUnclear
Unclear
YY
YY
Investigator
NA
NNo,NAnotavailable,Yyes
aInform
ationis
presentedas
thefirstauthorofthestudy,reference
number
inreference
list,andcountryin
whichthestudywas
conducted
1020
Table 3 Risk factors associated with time to death in multivariable models
Studya Risk factors associated with time to deathon multivariable analysis
Effect estimate (95 % CI) p value
Huynh [10] (60 min) Vasopresssors within 12 h of MVwithdrawal
2.05 (1.37–3.07)
FiO2[70 % 1.92 (1.24–2.98)Huynh [10] (10 h) Vasopresssors within 12 h of MV
withdrawal4.53 (1.52–13.45)
Primary service neurology/neurosurgical 0.30 (0.09–0.95)Brieva [11] (including ICU specialistopinion) (60 min)
Physician opinion 8.44 (4.3, 16.6)c \0.001pH 0.67 (0.47, 0.94) 0.03Systolic blood pressure 0.99 (0.98, 1.00) 0.01GCS 0.85 (0.74, 0.98) 0.03Positive end expiratory pressure 1.17 (1.1, 1.3) \0.01Analgesia 0.32 (0.15, 0.70) \0.01
Brieva [11] (excluding ICU specialistopinion) (60 min)
pH 0.57 (0.41, 0.81)c \0.01Systolic blood pressure 0.99 (0.98, 1.00) \0.01GCS 0.82 (0.72, 0.93) \0.01Positive end expiratory pressure 1.19 (1.08, 1.30) \0.001Analgesia 0.42 (0.21, 0.84) 0.02Spontaneous respiration rate 0.96 (0.94, 0.99) \0.01
Devila [17] (60 min) Age\40 years 3.62 (1.15, 11.4) 0.002No inotropes 0.19 (0.07, 0.52) 0.001No cough/gag 0.15 (0.05, 0.46) 0.001
deGroot [8] (Yee et al. validation [15],absent corneal, absent cough,extensor or absent motor response,oxygenation index[4.2) (60 min)
No other variables found to beindependently predictive of death within60 min on multivariable analysis
Rabinstein [12] (60 min) Absent corneal 2.67 (1.19, 6.01) 0.02Absent cough 4.16 (1.79, 9.70) \0.001Extensor or absent motor 2.99 (1.22, 7.34) 0.02Oxygenation index[3.0 2.31 (1.10, 4.85) 0.03
Shore [13] (60 min) Age\1 month 0.13Norepinephrine, epinephrine,phenylephrine
9.25
Extracorporeal life support 51.9PEEP[10 cmH2O 13.7[0 % spontaneous ventilation 0.59
Shore [13] (30 min) Age\1 month 0.12Norepinephrine, epinephrine,phenylephrine
12.0
Extracorporeal life support 12.3PEEP[10 cmH2O 3.0[0 % spontaneous ventilation 0.2
Wind [14] (60 min) Controlled mechanical ventilation 2.50 (1.18, 5.258) 0.02Wind [14] (120 min) Controlled mechanical ventilation 2.59 (1.17, 5.73) 0.02
Norepinephrine use 4.03 (1.43, 11.32) 0.01Cardiovascular comorbidity 0.32 (0.14, 0.69) 0.004
Yee [15] (60 min) Absent corneal 4.24 (1.57, 11.5) 0.005Absent cough 4.47 (1.93, 10.3) 0.0005Extensor or absent motor 2.83 (1.01, 7.91) 0.05Oxygenation Index 3.36 (1.33, 8.50) 0.01
Cooke [2] Age 0.95 (0.90, 0.99)d
Female 0.86 (0.77, 0.97)Nonwhite 1.17 (1.01, 1.35)4-year college degree 1.21 (1.01, 1.44)Surgical service 1.29 (1.06, 1.56)Vasopressors 1.67 (1.49, 1.88)Intravenous fluids 1.16 (1.01, 1.32)
Suntharalingam [16] (60 min) Age 31–40 years 0.70 (0.38, 1.28) 0.001Age 41–50 years 0.46 (0.29, 0.76) 0.008Age[50 years 0.37 (0.23, 0.59) 0.006Increased FiO2 1.01 (1.00, 1.02)Mode of ventilation: not pressure support 1.67 (1.16, 2.41)
Coleman [18] (60 min) Modified UNOS tool 4.90 (1.38, 17.60)
1021
predictive of time to death within 60 min in more thantwo studies are summarized in Table 4 and include age,female gender, controlled mode of ventilation, oxygena-tion [positive end expiratory pressure (PEEP)], partialpressure of oxygen or fraction of inspired oxygenthreshold, oxygenation index, hemodynamics, neurologicexam [Glasgow Coma Scale/Score (GCS) or brain stemreflexes), pH, simultaneous withdrawal of all supports,low analgesia, and physician opinion. Even though theabove risk factors were significant predictors in multiplestudies, the results were not consistent across all studiesthat examined the risk factors. Consistent predictors ofdeath which were identified in five or more studies werecontrolled mode of ventilation, risk factors associatedwith higher oxygenation requirements, use of vasopres-sors, and lower GCS or impaired brain stem reflexes.
Only one of the 15 studies reported risk factors asso-ciated with time to death within 120 min according tomultivariable logistic regression [14], namely, controlledmechanical ventilation, the use of norepinephrine, and thepresence of a cardiovascular comorbidity. One study re-ported on time to death within 10 h [10]; the authorsreported that use of vasopressors within 12 h prior towithdrawal and neurology/neurosurgery service not beingthe primary service at time of withdrawal were associatedwith a hastened death.
No consistent variables were found in the two pedi-atric studies to be associated with time to death; however,
age, vasopressor use, extracorporeal life support, higherPEEP, controlled mechanical ventilation, simultaneouswithdrawal, female sex, and the absence of continuousrenal replacement therapy were found to be associatedwith time to death in each individual study [13, 17].
When evaluating only the studies of DCD, the pre-dictors of death were similar. The most significantpredictors included controlled mode of ventilation (3studies), oxygenation (4), and neurologic function (3).
Ten studies evaluated the sensitivity and specificity oftheir derived models [6–9, 11–14, 17, 18], and fourstudies [8, 12, 17, 18] validated previously publishedmodels (summarized in Table 5).
The Wisconsin tool is an evaluation tool intended forpotential DCDs with severe neurologic injury who do notfulfill brain death criteria. The tool incorporates respira-tory rate and oxygenation after 10 min of disconnectionfrom the ventilator, tidal volume, negative inspiratoryforce, use of vasopressors, age, airway type, and bodymass index. A score between 10 and 23 is assigned basedupon these variables, with a higher score presumed to beassociated with a higher probability of death. In the initialvalidation study, the tool was found to have a sensitivityand specificity for predicting death within 60 min of 0.83and 0.84 and for predicting time to death within 120 minof 0.85 and 0.45; however when validated in a subsequentcohort, the results were not robust, with a lower sensi-tivity (0.42) and specificity (0.76) [18].
Table 3 continued
Studya Risk factors associated with time to deathon multivariable analysis
Effect estimate (95 % CI) p value
Devita [7] (general population)(60 min)
GCS = 3 2.83 (1.79, 4.46) \0.001SaO2/FiO2\230 1.78 (1.09, 2.90) \0.05Peak inspiratory pressure[35 2.58 (1.49, 4.48) \0.001Respiratory rate off ventilator\8 6.01 (2.29, 4.48) \0.001Diastolic blood pressure (10 mmHg) 0.80 (0.69, 0.93) \0.01PaO2\72 3.10 (1.53, 6.30) \0.01Epinephrine, norepinephrine orphenylephrine[0.2
3.02 (1.75, 5.21) \0.001
All treatments withdrawn within 10 min 8.55 (4.23, 17.30) \0.001Endotracheal tube withdrawn 2.28 (1.33, 3.90) \0.01Comfort medications given during firsthour after withdrawal of life sustainingtherapy
0.35 (0.21, 0.59) \0.001
Devita [7] (UNOS criteria)b 1 2.72e
2 4.62C3 10.60
Zawistowski [19] Simultaneous withdrawal of interventions \0.001Female 0.01No continuous RRT 0.02
CI Confidence interval, FiO2 fraction of inspired oxygen, GCSGlasgow Coma Scale/Score, MV mechanical ventilation, PaO2,partial pressure oxygen, PEEP positive end expiratory pressure,SPO2 Saturation level of oxygen in hemoglobina Information is presented as the first author of the study, followedby time to death criterion or other criteria
b UNOS criteria: see ESM Appendix 2 for full criteriac Relative risk (95 % CI)d Hazard ratios (95 % CI)e Unadjusted rates
1022
The UNOS tool was evaluated in two studies and is anumeric tool created to assess the likelihood of deathwithin 60 min; it relies upon a trial of disconnection fromventilation to evaluate spontaneous respirations andoxygenation [7, 18]. In addition, it incorporates hemo-dynamic variables and the presence of a series ofpharmacologic and mechanical hemodynamic supportdevices. Based upon the number of UNOS criteria pre-sent, a score is assigned between 0 and 5, with 5presumed to be associated with a higher likelihood ofdeath within 60 min. Coleman et al. [18] externallyvalidated an adapted version of the UNOS tool (i.e., theydid not disconnect patients from the ventilator and rede-fined ventilator dependence and oxygen disruption); theseauthors reported the UNOS tool to have a sensitivity of0.61 and specificity of 0.84. In the study by Devita et al.[7] among potential DCD patients, 33 % of those who hada UNOS score of 0 still died within 60 min. While thespecificity of the UNOS score was much better than thatreported by Coleman et al. [18] (88 % of those with 4criteria dying within 60 min), only two of the 505 patientshad a score of 4 or 5.
The Yee score was the first score to explore detailedneurologic predictor variables in a population of patientswith catastrophic neurologic disease [15]. The authorsidentified absent corneal reflex, absent cough reflex, ab-sent or extensor motor response, and an oxygenation
index of [4.2 as risk factors that were associated withtime to death within 60 min. The more features that arepresent, the higher the probability of death within 60 min.This model was further validated by de Groot et al. [8] ina similar population where it demonstrated moderatesensitivity (0.64) and specificity (0.72). These variableswere further evaluated and modified to create the DCD-Nscore by Rabinstein et al. [12] who used a differentoxygenation index cutoff. When evaluated in theirpopulation of neurologically impaired patients, itdemonstrated moderate sensitivity and specificity (0.72and 0.78, respectively); the specificity improved (0.91)when the oxygenation index was modeled as a continuousvariable.
In the Hunter New England Area Composite score, thecombination of ventilator dependence, oxygenation im-pairment, and systolic blood pressure of\100 mmHg wasassociated with a poor sensitivity (0.38) but high speci-ficity (0.96). This score has not been further validated[18].
In the Donors after cardiac death: Validating Identi-fication Criteria (DVIC) study, DaVita at al. [7] evaluatedpredictors of death in a general ICU population andconstructed decision rules for predicting death within60 min using the nonparametric Classification and Re-gression Tree Analyses (CART) model [7]. Of the modelsthey constructed, the best model incorporated depressed
Table 4 Common risk factors associated with time to death
Risk factor Studies evaluatingrisk factor in univariableanalysis (n)
Studies where risk factor wasstatistically significant inmultivariable analysis (n)
Demographic variablesAge[40 12 3Female 10 2Respiratory variablesControlled mode of ventilation, no spontaneous respirationsa 8 5OxygenationPositive end expiratory pressure 7 4PaO2 or FiO2 threshold 10 3Oxygenation indexb 3 3Hemodynamic variablesSystolic blood pressure 5 2Vasopressors 7 5Neurologic variablesGlasgow coma scale 6 3No cough/gag 5 3No corneal 4 2Absent or extensor motor 3 2Metabolic variablespH 4 2OtherSimultaneous WLST or within 10 min 2 2Physician opinion 3 2Less analgesia 3 2
Summary of variables that were statistically significant on multi-variable analysis in two of more studies for time to deathWLST withdrawal of life sustaining therapya Devita et al., respiratory rate\8 off ventilator
b Used as continuous variable for 1 study, threshold of[3.0 and 4.2used in two other studies
1023
Table
5Riskmodels,predictiontools
andperform
ance
VPN
VPPyticfiice pS
ytivitisneSC
UA
tnempoleve
Dled o
Mselbaira
Vcfiicep S
yd utS Brievaet
al.[9]
•ICU
specialistopinionof
death
New
lyDerived
?Validation(halfcohort)
Classificatio
nandRegression
Treeanalysis
(CART
Salfordsystem
s)
0.82
(v)
0.76
(v)
0.80
(v)
0.79
(v)
•Glasgow
comascale
•Sy
stolic
Blood
Pressure
•Po
sitiv
eendexpiratory
pressure
•Sp
ontaneousrespiratoryrate
Brievaet
al.[9]
•Excluding
ICU
specialistopinion
New
lyDerived
?Validation(halfcohort)
Classificatio
nandRegression
Treeanalysis
(CART
Salfordsystem
s)
0.62
(v)
0.78
(v)
0.77
(v)
0.65
(v)
•Glasgow
Com
aScale
•Sy
stolic
Blood
Pressure
•Po
sitiv
eendexpiratory
pressure
•Sp
ontaneousrespiratoryrate
Brievaet
al.[ 11]
•IncludingICU
specialistopinion
New
lyDerived
?Validation(halfcohort)
Multiv
ariableexplanatory
models
0.84
(v)
0.84
(v)
0.72
(v)
0.77
(v)
0.81
(v)
•Analgesia
•pH
•Glasgow
Com
aScale
•Sy
stolic
Blood
Pressure
•Po
sitiv
eendexpiratory
pressure
Brievaet
al.[11]
•Excluding
ICU
specialistop
inion
New
lyDerived
?Validation(halfcohort)
Multiv
ariableexplanatory
models
0.78
(v)
0.82
(v)
0.59
(v)
0.68
(v)
0.75
(v)
•Analgesia
•pH
•Glasgow
Com
aScale
•Sy
stolic
Blood
Pressure
•Po
sitiv
eendexpiratory
pressure
•Sp
ontaneousrespiratoryrate
DeV
ilaet
al.[7]
•citsigol
elbairavitluM
devireD
ylwe
Neg a
ronoD
regression
model
0.83
•Gag
orcoughreflex
•Inotropicsupport
•Bodymassindex
•ICU
length
ofstay
•Liver
enzymes
deGroot
etal.[ 8]
•Corneal
reflex
Validation
Re-evaluatedYee
etal
variablesusingmultiv
ariable
logistic
regression
analysis
0.77
•Cough
reflex
•Motor
reflex
•Oxygenatio
nindex
Rabinsteinet
al.[12]
•Corneal
reflex
Validation
Re-evaluatedYee
etal
variablesusingmultiv
ariable
logistic
regression
analysis
0.81
0.72
0.78
•Cough
reflex
•Motor
reflex
•Oxygenatio
nindex
Windet
al.[14 ]
(60min)
•Controlledmechanicalventilatio
nNew
lyDerived
Multiv
ariablelogistic
regression
analysis
0.74
0.70
0.74
Windet
al.[14]
(120
min)
•Controlledmechanicalventilatio
nNew
lyDerived
Multiv
ariablelogistic
regression
analysis
0.76
0.84
0.52
•Norepinephrineadministration
•cardiovascular
comorbidity
Colem
anet
al.[18]
•09.0
67.098.0
87.0devire
Dyl
weN
n oini potsil aiceps
UC I
1024
Table
5continued
VPN
VPPyticfiicepS
ytivitisneSC
UA
tnempoleve
Dled o
Mselbaira
Vcfiice pS
y dutS Colem
anet
al.[ 18
26.085.0
67.024.0
n oita dilaV
lo oT
nis noc siW
]•Bodymassindex
•Vasopressor
use
•Age
•Route
ofintubatio
n•Sp
ontaneousrespiratoryrate
•Negativeinspiratoryforce
•Tidal
volume
•Oxygensaturatio
nColem
anet
al.[ 18
37.067.0
48.016.0
n oitadilaV
er ocSS
ON
U]
Colem
anet
al.[ 18]
•66.0
78.069.0
93.0noitadila
Vecne dn epe d
rotalitneV
•Oxygenatio
n•Sy
stolic
bloodpressure
DeV
itaet
al.[7]
•With
draw
alprocessvariablesa
New
lyDerived
Multiv
ariableexploratory
analysis,Nonparametric
Classificatio
nand
RegressionTreeanalysis
(CARTSalfordsystem
s)
0.79
0.63
0.63
0.78
•Glasgow
comascale
•SaO2/FiO2
•Peak
inspiratorypressure
Lew
iset
al.[6]
(60min)
Wisconsin
tool
bNew
lyDerived
Variables
included
basedupon
clinical
ratio
nale
0.73
0.84
0.84
•Bodymassindex
•Vasopressor
use
•Age
•Route
ofintubatio
n•Sp
ontaneousrespiratoryrate
•Negativeinspiratoryforce
•Tidal
volume
•Oxygensaturatio
nLew
iset
al.[6]
(120
min)
Wisconsin
tool
bNew
lyDerived
Variables
included
basedupon
clinical
ratio
nale
0.85
0.45
•Bodymassindex
•Vasopressor
use
•Age
•Route
ofintubatio
n•Sp
ontaneousrespiratoryrate
•Negativeinspiratoryforce
•Tidal
volume
•Oxygensaturatio
n
ALTalanineam
inotransferase,
AUC
area
under
thecurve,
ICU
intensivecare
unit,NPVnegativepredictivevalue,
OIoxygenationindex,PIP
peakinspiratory
pressure,PPV
positivepredictivevalue,
(v)validationcohort,UNOSUnited
Network
forOrgan
Sharing
aWithdrawal
within
10min,ETTremoval,comfortmeasuresgiveduringfirsthourafterwithdrawal
bRespiratory
variablesmeasuredafterdiscontinuationofmechanical
ventilationfor10min
1025
GCS, impaired saturation level of oxygen in hemoglobin/fraction of inspired oxygen (SaO2/FiO2), peak elevatedinspiratory pressure, and all treatments withdrawn within10 min. The more features present, the higher likelihoodof death within 60 min. This yielded a sensitivity andspecificity of 0.75 and 0.73, respectively. This model wasnot externally validated in another population.
In the logistic regression model by Brieva et al. [11](the PREDICT study), applied to the validation cohort ofa general ICU population, the best model included ICUspecialist opinion, pH, systolic blood pressure, GCS,PEEP and lower analgesia. These factors were found to beassociated with time to death with a sensitivity andspecificity of 0.84 and 0.72, respectively. In a subsequentstudy which focused on the potential DCD subgroupwithin their original cohort study, these authors developedCART models to create decision tree analysis for time todeath within 60 min. Their best model included ICUspecialist opinion, PEEP, GCS, spontaneous respiratoryrate, and systolic blood pressure with a sensitivity andspecificity of 0.82 and 0.76, respectively [9].
Discussion
This is the first systematic review to evaluate time todeath after WLST. Across 15 studies we identified asignificant amount of heterogeneity with respect to patientpopulation and variables incorporated into the exploratoryprediction models. While this heterogeneity prevented ameta-analysis, we were able to gain significant insightinto the most consistent key predictor variables associatedwith time to death across different populations whichprimarily focused on time to death within 60 min,namely, controlled mechanical ventilation, risk factorsrelated to oxygenation impairment, vasopressor use, andneurologic function. These predictor variables were con-sistent across the studies involving general ICU patientsand those focusing primarily on DCD candidates.
Neurologic- and respiratory-related risk factors werethe most consistent variables across all studies associatedwith time to death. A lower GCS, absence of cough/gag,and absent corneal reflexes/extensor motor reflexes wereassociated with faster time to death. Clinically, patientswith these risk factors likely have a catastrophic neuro-logic injury that does not progress to brain death. Thepathway by which these variables lead to a hastened deathis possibly associated with the loss of sufficient respira-tory effort due to brainstem injury. Thus, the removal ofventilator support likely leads to a rapid rise in the partialpressure of CO2, leading to a significant respiratory aci-dosis and hemodynamic collapse. Additionally, thosepatients with a significant amount of neurologic ischemia,clinically manifested by a depressed GCS or loss ofbrainstem reflexes, may develop hemodynamic instability
as a result of a cascade of inflammatory mediator releaseassociated with cellular necrosis [23].
Respiratory-related risk factors are also strongly cor-related with time to death, with the most consistentvariables being controlled mode of ventilation and/or ahigher level of oxygen support. The etiology behind thecessation of spontaneous respiration, necessitating a con-trolled mode of ventilation, is often linked to catastrophicneurologic brainstem injury. Similar to the rationale forhastened death in the setting of neurologic risk factors, thewithdrawal of ventilator support may often lead to a rapiddeath associated with a rapid development of respiratoryacidosis. In addition, the withdrawal of high levels ofoxygen support (FiO2 or PEEP) has also been associatedwith a shorter time to death across a subset of studies.Ensuing hypoxia likely results in anaerobic metabolism,severe lactic acidosis, cellular death, and electrolyte andhemodynamic instability, ultimately leading to death: thehigher the oxygen support, presumably the more rapid thedevelopment of these changes.
Sedation and symptom management is a cornerstoneof palliative care management. While it may be postu-lated that increased sedation could hasten death byblunting the respiratory drive and inducing hemodynamicinstability, this has not been demonstrated in the reviewedstudies [5, 9, 12]. In fact, in some of the reviews, themanagement of sedation and symptoms has been associ-ated with an increased time to death [18]. One possibleexplanation for this relationship may be the inverse re-lationship between the depth of coma and symptomswarranting sedation after WLST.
Physician opinion has not been evaluated extensively,in part because traditionally physician opinion has notbeen considered to accurately predict time to death,thereby leading to the search for more accurate predictiontools [12]. However, the findings by Brieva and col-leagues [9] are intriguing as in their study physicianopinion was strongly associated with time to death(relative risk 8.44; 95 % confidence interval 4.3, 16.6).Given this significant association, the role of physicianopinion in predicting time to death warrants furtherevaluation.
Few studies included in this review described thestepwise approach to WLST, which includes actionssurrounding extubation, sedation management, and va-sopressor weaning and cessation, and whether they occursimultaneously or in a staged fashion. Differences inpractice could have an important impact on time to death.Removal of the endotracheal tube during WLST wasevaluated in a few studies but did not consistently cor-relate with time to death [7, 14].
Across the seven prediction tools proposed, only a fewwere validated in a separate cohort, and most had onlymoderate sensitivity. The University of Wisconsin toolunderwent external validation in the study by Colemanet al. [18] and only demonstrated moderate sensitivity and
1026
specificity. The major difference between the initial tooldevelopment study and the validation study was that thepopulation in the development study suffered from severeneurological injury while the validation study included ageneral ICU population, which may make the tool lessreliable. While the UNOS tool and a modified formatwere externally validated in two studies of a general ICUpopulation [7, 18], one possible explanation for the lackof external validity could stem from the tool’s heavy fo-cus on hemodynamic support devices, suggesting that itmay be most applicable in units which frequently employthese devices, such as cardiac units. The Yee tool, whichwas originally derived from a neurologic ICU population,was further externally validated by two studies using asimilar population. Brieva et al. [11] validated theirderived CART models in their two studies using a sepa-rate validation cohort; these models have not undergonefurther external validation. The Hunter New EnglandArea Composite score and the DVIC CART models havenot yet undergone further external validation.
There are a series of limitations in our study worthnoting. First, this review focused heavily on time to deathwithin 60 min due to the state of the current literature; thisreview therefore provides useful information for practi-tioners interested in that time-point. However, regardingthe general ICU population, it is not uncommon forfamilies to inquire if death will occur ‘‘immediately’’following withdrawal. Additionally, for the purpose ofDCD, new standard wait times are approaching 120 minas opposed to the traditional 60 min (depending upon or-gan of interest). Therefore, different time-points ofevaluation should be considered in future studies. Second,this review highlights predictors of time to death that wereconsistent across many of the studies included in the re-view. However, not every study evaluated the same list ofrisk factors, thereby limiting our ability to draw any con-clusions about those risk predictors found to be stronglyassociated with our outcome of interest yet only evaluatedin a small number of studies. Third, these studies wereheterogeneous in terms of the patient populationsevaluated. Predictors of time to death in the catastrophicneurologic disease population may be very different thanthose in the population with catastrophic medical disease.
While this review is the first to highlight the mostconsistent and important risk factors associated with timeto death and has identified promising novel features
demonstrating significance but for which reproducibilityis pending, it also highlights the paucity and heterogeneityof the data that currently exist on this topic. Moving forth,subsequent research must not only include all of thevariables that were found here to be consistently associ-ated with time to death but must also evaluate theirpredictive ability in the general medical population aswell as in specific subgroups, including patients withcatastrophic neurologic injury and donation after cardiacdeath candidates. In addition, different time-points shouldbe explored, and there should be a more detailed overviewof withdrawal practices and the differential effect of si-multaneous withdrawal compared to a staged process ifboth options are available.
Conclusions
Knowledge of time to death can help inform decisions onpalliation as well as assist with family preparedness andease the grieving process. In addition, time to death is im-portant for DCD as accurate prediction can have an impacton resource use and can reliably inform family discussions.This study highlights the significant work that has beenaccomplished thus far in the field in identifying consistentvariables associated with time to death, namely, controlledventilation, oxygenation, vasopressor use, GCS, and brainstem reflexes. It can inform future research endeavors fo-cused on the development ofmore accurate prediction toolsfor generalized ICU, neurologic ICU, and DCD popula-tions. Important questions that remain and need to be morerigorously studied include various time-points of death aswell as method of withdrawal. These have important im-plications for end-of-life care in the ICU.
Acknowledgments Laveena Munshi receives funding from theEliot Phillipson Clinician Scientist. Training Program, Departmentof Medicine, University of Toronto. Jason Shahin receives fundingsupport from the Department of Medicine, McGill UniversityHealth Centre.
Conflicts of interest The authors declare that they have no con-flicts of interest. Sonny Dhanani is the Chief Medical Officer ofTrillium Gift of Life Network. Sam Shemie is a medical advisor tothe Canadian Blood Services.
References
1. Carlet J, Thijs LG, Antonelli M et al(2004) Challenges in end-of-life care inthe ICU. Statement of the 5thinternational consensus conference incritical care: Brussels, Belgium, April2003. Intensive Care Med30(5):770–784
2. Cooke C, Hotchkin D, Engelberg R et al(2010) Predictors of time to death afterterminal withdrawal of mechanicalventilation in the ICU. Chest138(2):289–297
3. Dhanani S (2014) Chief MedicalOfficer, Trillium Gift of Life Network.Personal correspondence
4. Shemie SD, Baker AJ, Knoll G et al(2006) National recommendations fordonation after cardiocirculatory death inCanada: donation after
1027
cardiocirculatory death in Canada. CanMed Assoc J 175(8):S1
5. Muskett H, Shahin K, Eyres G et al(2011) Risk factors for invasive fungaldisease in critically ill adult patients: asystematic review. Crit Care15(6):R287
6. Lewis J, Peltier J, Nelson H et al (2003)Development of the University ofWisconsin Donation after cardiac deathevaluation tool. Prog Transplant13:265–273
7. DeVita M, Mori Brooks M,Zawistowski C et al (2008) Donors aftercardiac death: validation ofidentification criteria (DVIC) study forpredictors of rapid death. Am JTransplant 8:432–441
8. de Groot Y, Lingsma H, Bakker J et al(2012) External validation of aprognostic model predicting time ofdeath after withdrawal of life support inneurocritical patients. Crit Care Med40(3):233–238
9. Brieva J, Coleman N, Lacey J, et al(2014) Prediction of death in less than60 minutes after withdrawal ofcardiorespiratory support in potentialorgan donors after circulatory death.Transplantation 8(10):1112–1118
10. Huynh T, Walling AM, Le TX et al(2013) Factors associated withpalliative withdrawal of mechanicalventilation and time to death afterwithdrawal. J Palliat Med16(11):1368–1374
11. Brieva J, Coleman N, Lacey J et al(2013) Prediction of death in less than60 minutes following withdrawal ofcardiorespiratory support in ICUs. CritCare Med 41(12):2677–2687
12. Rabinstein AA, Yee AH, Mandrekar Jet al (2012) Prediction of potential fororgan donation after cardiac death inpatients in neurocritical state: aprospective observational study. LancetNeurol 22:414–419
13. Shore P, Huang R, Roy L et al (2012)Development of a bedside tool topredict time to death after withdrawalof life-sustaining therapies in infantsand children. Pediatr Crit Care Med13:415–422
14. Wind J, Snoeijs M, Brugman CA et al(2012) Prediction of time of death afterwithdrawal of life-sustaining treatmentin potential donors after cardiac death.Crit Care Med 40:766–769
15. Yee AH, Rabinstein AA, Thapa P et al(2010) Factors influencing time to deathafter withdrawal of life support inneurocritical patients. Neurology74:1380–1385
16. Suntharalingam C, Sharples L, DudleyC et al (2009) Time to cardiac deathafter withdrawal of life-sustainingtreatment in potential organ donors. AmJ Transplant 9:2157–2165
17. Davila D, Ciria R, Jassem W et al(2012) Prediction models of donorarrest and graft utilization in livertransplantation from Maastricht-3
donors after circulatory death. Am JTransplant 12(12):3414–3424
18. Coleman N, Brieva J, Crowfoot E(2008) Prediction of death afterwithdrawal of life-sustainingtreatments. Crit Care Resusc10:278–284
19. Zawistowski C, DeVita M (2004) Adescriptive study of children dying inthe pediatric intensive care unit afterwithdrawal of life-sustaining treatment.Pediat Crit Care Med 5(3):216–223
20. Chan JD, Treece PD, Engelberg RAet al (2004) Narcotic andbenzodiazepine use after withdrawal oflife support: association with time todeath? Chest 126:286–293
21. NSW Health Department (2007) Organdonation after cardiac death. Health andresearch and ethics. File No 04/3586-2.NSW Department of Health, Sydney
22. Levvey B, Westall G, Kotsimbos T et al(2008) Definitions of warm ischemictime when using controlled donationafter cardiac death lung donors.Transplantation 86(12):1702–1706
23. Powner DJ, Hendrich A, Nyhuis A,Strate R (1992) Changes in serumcatecholamine levels in patients whoare brain dead. J Heart Lung Transplant11(6):1046–1053
1028